Caribou Biosciences, Inc. (CRBU)
1.435
-0.02
(-1.71%)
USD |
NASDAQ |
Jan 20, 11:30
Caribou Biosciences EPS Diluted (Quarterly): -0.2953 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.0626 |
| GT Biopharma, Inc. | -0.8268 |
| Phio Pharmaceuticals Corp. | -0.4374 |
| Daré Bioscience, Inc. | -0.2793 |
| Nurix Therapeutics, Inc. | -1.027 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.55M |
| Revenue (Quarterly) | 2.198M |
| Total Expenses (Quarterly) | 29.75M |
| Enterprise Value | 14.67M |
| Gross Profit Margin (Quarterly) | 71.29% |
| Profit Margin (Quarterly) | -1.25K% |
| Earnings Yield | -118.3% |
| Normalized Earnings Yield | -107.66 |